干扰素调节因子-4结合蛋白与癌症的相关研究进展

doi:10.11904/j.issn.1002-3070.2017.01.020

Abstract

Abstract: Interferon regulatory factor-4 binding protein(IBP),served as a novel type of microtubule binding protein,is proven to play an important role in the immune system.New evidence suggests that the protein is associated with the occurrence and development of some malignant tumors through the effects of cytoskeletal remodeling and cell conduction mechanism.Therefore researchers believe that IBP may become a new target for cancer molecular therapy.Based on the existing experimental data,this study aims to investigate the structure of IBP,as well as its multiple oncology effects.Furthermore,we provide the theoretical basis for IBP targeted therapy in the treatment of malignant tumors.

Key words: IBP, Structural-function, Tumor, Mechanism

CLC Number:

R730.3

HOU Yangming, XU Yingjuan, CUI Yunfu. Advances in the tumor related research of IRF-4 binding protein[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(1): 93-96.

References

1 Hu CM,Jang SY,Fanzo JC,et al.Modulation of T cell cytokine production by interferon regulatory factor-4[J].J Biol Chem,2002,277(51):49238-49246.
2 Shu CL,Jing YL,Su LC,et al.SWAP-70:a new type of oncogene[J].PLoS One,2013,8(3):e4422.
3 Gupta S,Lee A,Hu C,et al.Molecular cloning of IBP,a SWAP-70 homologous GEF,which is highly expressed in the immune system[J].Hum Immunol,2003,64(4):389-401.
4 Liu JJ,Lin M,Yu JY,et al.Targeting apoptotic and autophagic pathways for cancer therapeutics[J].Cancer Lett,2011,300(2):105-114.
5 Lazer G,Katzav S.Guanine nucleotide exchange factors for RhoGTPases:good therapeutic targets for cancer therapy?[J].Cell Signal,2011,23(23):969-979.
6 Srougi MC,Burridge K.The nuclear guanine nucleotide exchange factors Ect2 and Net1 regulate RhoB-mediated cell death after DNA damage[J].PLoS One,2011,6(2):e17108.
7 Chen Q,Gupta S,Pernis AB.Regulation of TLR4-mediated signaling by IBP/Def6,a novel activator of Rho GTPases[J].J Leukoc Biol,2009,85(3):539-543.
8 Goudevenou K,Martin P,Yeh YJ,et al.Def6 is required for convergent extension movements during zebrafish gastrulation downstream of Wnt5b signaling[J].PLoS One,2011,6(10):e65.
9 Burgess DJ.Breast cancer:circulating and dynamic EMT[J].Nat Rev Cancer,2013,13(3):148-149.
10 Peng L,Zhang Z,Wang Q,et al.The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells[J].Int Immunopharmacol,2009,9(7/8):1002-1009.
11 Yang M,Fang Y,Peng L,et al.Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells[J].Mol Cancer,2011,11(1):1-13.
12 Chen S,Han Q,Wang X,et al.IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway[J].Cell Death Dis,2013,4(10):377-377.
13 杨明珍.乳腺癌中IBP的转录调控机制及其意义的初步研究[D].北京:第三军医大学,2012.
14 Zhang Z,Wang Q,Peng L,et al.Overexpression of the interferon regulatory factor 4-binding protein in human colorectal cancer and its clinical significance[J].Cancer Epidemiol,2009,33(2):130-136.
15 Vistica BP,Shi G,Nugent L,et al.SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis(EAU)[J].Mol Vis,2012,18(192):1858-1864.
16 何颖,张竹君.IBP通过上皮间质转化促进结肠癌细胞迁移和侵袭[J].第三军医大学学报,2016,38(11):1281-1285.
17 Tiwari N,Gheldof A,Tatari M,et al.EMT as the ultimate survival mechanism of cancer cells[J].Semi in Cancer Biol,2012,22(22):194-207.
18 张竹君.特异性IRF-4结合蛋白(IBP)多克隆抗体制备及其在人结肠癌中表达模式的初步研究[D].北京:第三军医大学,2009.
19 Gulhati P,Bowen KA,Liu J,et al.MTORC1 and mTORC2 regulate EMT,motility,and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways[J].Cancer Res,2011,71(9):3246-3256.
20 Chang YJ,Cheng YW,Lin RK,et al.Thrombomodulin influences the survival of patients with non-metastatic colorectal cancer through epithelial-to-mesenchymal transition(EMT)[J].PLoS One,2016,11(8):e0160550.
21 Shuman Moss LA,Jensen-Taubman S,Stetler-Stevenson WG.Matrix metalloproteinases:changing roles in tumor progression and metastasis[J].Am J of Pathol,2012,181(6):1895-1899.
22 简从相,黄晓山,李晨军.IRF-4结合蛋白在口腔鳞癌中的表达及临床意义[J].实用口腔医学杂志,2012,28(4):478-481.
23 潘磊,简从相,李卓,等.IRF-4结合蛋白对口腔鳞癌细胞生长作用的机制研究[J].西南国防医药,2014,24(5):468-470.
24 石俊婷,赵凌,蔡双兵,等.IBP对口腔鳞癌增殖作用的体内研究[J].西南国防医药,2014,24(9):951-953.
25 熊剑,简从相,李鹏,等.IRF-4结合蛋白对人涎腺腺样囊性癌细胞增殖的抑制作用[J].第三军医大学学报,2011,33(6):554-557.
26 熊剑.IBP(IRF-4结合蛋白)在人涎腺腺样囊性癌中表达及功能的实验研究[D].北京:第三军医大学,2011.
27 Ishii K,Shimoda M,Sugiura T,et al.Involvement of epithelial-mesenchymal transition in adenoid cystic carcinoma metastasis[J].Int J Oncol,2011,38(4):921-931.
28 Radisky DC,Levy DD,Littlepage LE,et al.Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability[J].Nature,2005,436(7047):123-127.
29 熊剑,常慧君,李鹏,等.IBP促进人涎腺腺样囊性癌细胞对紫杉醇耐药[J].第三军医大学学报,2012,34(8):723-725.

[1]	ZHANG Maoxiang,SUN Huixin,SONG Bingbing. Analysis of the incidence and mortality of malignant tumors in Daoli District,Harbin,2008—2012 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 261-265.
[2]	LIU Yishu,QU Guofan. Progress in long-chain non-coding RNA in osteosarcoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 266-270.
[3]	HOU Yuxue,LI Xiaoli. The research progress of Wnt7a and malignant tumors,and its relationship [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 271-275.
[4]	XU Hui, LI Xi, ZHOU Chunshui. Screening of lung cancer tumor-associated suppressor genes using shRNA library targeting human transcriptome [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 97-102.
[5]	YUAN Guixia, LI Yan, FENG Wanqi, XIA Xiaojuan, LI Xu. Mechanism of tumor suppressor gene DKK2 inhibiting proliferation of nephroblastoma cells in children [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 14-20.
[6]	CHANG Xiaoxia, SONG Bingbing, LIU Jiaren. Research progress in phytochemicals for increasing sensitivity of tumor cells to chemotherapies [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 67-72.
[7]	DING Jiexian, ZHANG Jin, CHEN Yonggang, WANG Xingwen, WANG Shuanke. Progress in Wnt signaling pathway and tumorigenesis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 73-77.
[8]	KAN Jun, ZHOU Daihan, ZHANG Enxin. Research progress in tumor with cardiovascular disease [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 558-561.
[9]	LIU Juan, ZHANG Shutian. Advances in research on the mechanism of cyclin-dependent kinase inhibitor 3(CDKN3)in tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 575-578.
[10]	LI Yue, XU Ke, HAN Zengxiang, SUN Min, FAN Guohua, ZHANG Yong. Advances in the role of tumor-associated macrophage in colon cancer and targeted therapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 450-454.
[11]	WANG Yuan, SUN Yihua. Advance in the role of β-catenin in soft tissue tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 455-459.
[12]	ZHANG Yali, SU Danke. Research progress in gadolinium-based molecular probes for tumor targeting imaging [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 460-463.
[13]	HAN Bangling, WANG Yimin, XUE Yingwei. Research progress of vitamin D in tumors of digestive system [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 471-475.
[14]	HAN Bangling,WANG Yimin,XUE Yingwei. Research progress in the relationship between neutrophils and malignant tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 349-352.
[15]	ZHANG Yiyun,WU Huaxing. Progress of metabolic plasticity in tumor growth and metastasis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 362-366.

Advances in the tumor related research of IRF-4 binding protein

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments